BTIG Maintains Buy on IperionX, Raises Price Target to $55

Benzinga Newsdesk www.benzinga.com Positive 59.1%

Neg 0% Neu 0% Pos 59.1%

BTIG analyst Gregory Lewis maintains IperionX (NASDAQ:IPX) with a Buy and raises the price target from $40 to $55.

Comments

No comments yet. Be the first!